All Disease Treatment & Prevention articles – Page 5
-
NewsOral chiral nanozyme protects the heart during chemotherapy by reshaping the gut-heart axis
A chirality-engineered nanozyme restores gut microbiota and host metabolism to prevent doxorubicin-induced cardiotoxicity without compromising anticancer efficacy.
-
NewsStudy supports effectiveness of RSV preventive antibody treatments for infants and provides new way to monitor viral resistance
An analysis of more than 60,000 respiratory syncytial virus (RSV) sequences from around the world found that viral variants associated with resistance to current RSV prevention tools remain rare, according to a study.
-
NewsResearchers discover how Epstein-Barr Virus triggers multiple sclerosis attacks
In a study of blood samples from more than 100 participants with MS, researchers detected increased EBV lytic activity in immune cells up to three months before MS relapse and discovered that these cells also showed elevated expression of genes linked to MS risk.
-
NewsBeyond the gut: Necrotizing enterocolitis drives neurodevelopmental impairment through gut-derived inflammation
A severe gut disease in premature infants, known as necrotizing enterocolitis (NEC), does far more than damage the intestines—it fundamentally alters brain development, leaving up to 40% of survivors with lasting cognitive, motor, and behavioral impairments.
-
NewsCan probiotics help T cells fight solid tumors more effectively?
Transferred T cells often have difficulty reaching tumors and overcoming the strongly immunosuppressive environment surrounding cancer cells. Researchers have combined therapeutic T cells with engineered probiotics, physically attaching the bacteria to the surface of T cells to create a hybrid system called T-FOLactis.
-
NewsGut bacterial enzyme worsens colitis by switching off a protective intestinal signal
Microbiome research often focuses on which microbes are present in the gut and what small molecules they produce. But gut bacteria also make enzymes that can act directly on molecules produced by the host. Researchers report that one such bacterial enzyme can weaken a protective intestinal signal and aggravate colitis in a preclinical model.
-
NewsScientists discover why shingles pain can last after virus is gone
Researchers have discovered that small particles in the blood called exosomes are the likely culprit behind why some people with shingles experience lingering pain long after virus has cleared their body.The study investigated the cause of post-herpetic neuralgia (PHN) in patients infected with the varicella zoster virus.
-
NewsFecal microbiota transplantation may improve immunotherapy-related colitis
Targeting the gut microbiome with fecal microbiota transplantation may help cancer patients with immunotherapy-related colitis avoid the need for steroids and other immune-suppressing treatments, according to researchers.
-
NewsWhen antiviral defense and autoimmunity collide: New insights into lupus genetics
Researchers have found that a common lupus-associated genetic variant may strengthen antiviral immune responses while increasing the risk of autoimmunity.
-
NewsThe Wistar Institute wins $15M+ NIH investment to advance HIV cure research strategies
The Wistar Institute has announced the National Institutes of Health (NIH) has awarded two major grants totaling more than $15M to Luis J. Montaner, D.V.M., D.Phil., director of Wistar’s HIV Cure and Viral Diseases Center.
-
NewsPaper reveals huge enthusiasm for Caribbean microbiome hub at inaugural symposium
Turnout at a recent symposium has confirmed the appetite for a new microbiome hub in Puerto Rico, reveals Puerto Rico AMI Global Ambassador Dr. Filipa Godoy-Vitorino.
-
NewsGut, airway and tumor microbes emerge as promising predictors of immunotherapy response in lung cancer
A comprehensive review systematically evaluates the microbiome’s role in lung cancer immunotherapy. Authors synthesized evidence covering microbial communities in the oral cavity, airways, lung tumors and gut, and their connections to treatment efficacy and immune‑related adverse events.
-
NewsFusobacterium nucleatum drives immunosuppression and metastasis in TNBC
A new study identifies Fusobacterium nucleatum, a Gram-negative anaerobic bacterium associated with several cancers, as a key driver of tryptophan metabolic reprogramming, immunosuppression and lung metastasis in triple-negative breast cancer.
-
NewsExpert consensus outlines 12 recommendations to prevent secondary mucormycosis after respiratory viral infections
The recommendations focus on defined high-risk patients, early viral testing and treatment, hospital infection control, and practical measures for resource-limited settings.
-
NewsNew research offers avenue to explore relationship between Alzheimer’s and HIV
Researchers have created an animal model that helps resolve questions about the relationship between HIV and Alzheimer’s disease (AD). The virus that drives the root cause of AD initiates a complex chain that, with other disease partners, drives nerve cell injury and cognitive impairments for AD pathology.
-
NewsBacterial trial fails to demonstrate early asthma prevention - prompting rethink of 'hygiene hypothesis'
A national clinical trial has found that treating young children with an oral bacterial extract did not reduce the risk of severe wheezing and respiratory illnesses that can precede asthma, potentially prompting researchers to rethink aspects of the hygiene hypothesis.
-
NewsHigh-dose flu vaccine beneficial for older people with lung disease
The risk of being hospitalised for flu or pneumonia can be reduced with a high-dose flu vaccine for older people with chronic lung disease, according to the combined results of two large clinical trials.
-
NewsHaving COVID-19 is associated with lower subsequent development of type 1 diabetes among those aged under 30 years
New research shows that people who have had COVID-19 have a lower, rather than higher, risk of subsequent development of type 1 diabetes (T1D). Furthermore, the effect is evident only in people who did not receive the SARS-CoV-2 vaccine.
-
NewsSmall bowel microbiome offers clues to women’s health
A new study has identified differences in the makeup and organization of the small bowel microbiome between women and men. One intriguing finding was a bacterial community containing Granulicatella, found only in women.
-
NewsKazakh researchers ID antiviral and anti-inflammatory compounds in native medicinal plants
Researchers have identified biologically active compounds with antiviral, antimicrobial, and anti-inflammatory effects in several plant species native to Kazakhstan, providing new chemical and experimental data on medicinal flora from Central Asia.